| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/11/2010 | EP2216344A1 Diagnosis and treatment of cancer using anti-gpr49 antibody |
| 08/11/2010 | EP2216343A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/11/2010 | EP2215126A2 Compositions and methods to modulate cell membrane resealing |
| 08/11/2010 | EP2215122A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 08/11/2010 | EP2215114A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 08/11/2010 | EP1827492B1 Antibodies directed to gpnmb and uses thereof |
| 08/11/2010 | CN1817909B Double-functional blended protein |
| 08/11/2010 | CN101802195A PVII phage display |
| 08/11/2010 | CN101801409A compositions comprising pneumococcal antigens |
| 08/11/2010 | CN101798351A Recombinant expression of human TIM-1-Fc fusion protein |
| 08/11/2010 | CN101798350A Fusion protein of human interferon alpha-2b and human thymosin alpha1, and preparation thereof |
| 08/11/2010 | CN101319012B Calcitonin-gene-related peptide and trout calcitonin amalgamation polypeptide |
| 08/10/2010 | US7772386 immunization against Mycobacterium tuberculosis; purified nucleic acid molecule coding for oxidoreductase from M. tuberculosis; production of a vaccine against a virulent strain of M. tuberculosis |
| 08/10/2010 | US7772385 nucleotide sequences coding novel g-protein coupled receptors for identifying modulators of sweet taste transduction |
| 08/10/2010 | US7771970 Protein fusion comprising sequences capable of being cleaved by ubiquitin cleavage enzyme; isolating heterologous expressed, recombinant polypeptide from mixture |
| 08/10/2010 | US7771721 Methods for using chimeric vascular endothelial growth factor receptor proteins |
| 08/10/2010 | CA2319309C Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 08/10/2010 | CA2175567C Chimeric proteins comprising borrelia polypeptides: uses therefor |
| 08/05/2010 | WO2010088160A1 T cell receptors and related materials and methods of use |
| 08/05/2010 | WO2010087972A2 Il-1 binding proteins |
| 08/05/2010 | WO2010086602A1 Hybridization linkers |
| 08/05/2010 | US20100197895 Antibodies to human tumor necrosis factor receptor |
| 08/05/2010 | US20100196989 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
| 08/05/2010 | US20100196458 Modified cytokines for use in cancer therapy |
| 08/05/2010 | US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS |
| 08/05/2010 | US20100196397 Five-helix protein |
| 08/05/2010 | US20100196372 FcgammaRIIB Fusion Proteins and Compositions Thereof |
| 08/05/2010 | US20100196266 Humanized Anti-HLA-DR Antibodies |
| 08/05/2010 | DE102009008252A1 Autokatalytischer Proteinlinker und seine Verwendung zur Herstellung von Fusionsproteinen Autocatalytic protein linker and its use for the production of fusion proteins |
| 08/05/2010 | CA2750922A1 Li-key hybrid peptides that modulate the immune response to influenza |
| 08/05/2010 | CA2750874A1 Hybridization linkers |
| 08/04/2010 | EP2213743A1 Albumin fusion proteins |
| 08/04/2010 | EP2213735A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same |
| 08/04/2010 | CN101792491A Recombinant adenovirus HIV vaccine based on multipleseries epi-position and preparation method thereof |
| 08/04/2010 | CN101791409A peptide vectors |
| 08/03/2010 | US7767212 compositions and vaccines comprising at least one Fel d1 antigen or fragment thereof are not only capable of inducing immune responses against Fel d1, and hereby in particular antibody responses, but are, furthermore, capable of desensitizing a patient suffering from cat allergy |
| 08/03/2010 | CA2353603C Udp-n- acetyl glucosamine: galactose-.beta.1, 3-n- acetyl galactosamine- .alpha.-r/ n- acetyl glucosamine -.beta.1, 3-n- acetyl galactosamine- .alpha.-r (glcnac to galnac) .beta.1,6-n- acetyl glucosaminyl transferase, c2/4gnt |
| 08/03/2010 | CA2133873C Tnf inhibitors |
| 07/29/2010 | WO2010084851A1 Peptide capable of binding to immunoglobulin |
| 07/29/2010 | WO2009073808A3 Compositions and methods to modulate cell membrane resealing |
| 07/29/2010 | US20100190211 IL-18 Receptors |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189718 Molecules with extended half-lives, compositions and uses thereof |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/28/2010 | EP2210904A1 Fusion protein comprising tumor necrosis factor related apoptosis inducing ligand and integrin ligand and use thereof |
| 07/28/2010 | CN101787081A Thymosin alpha1-thymopoietin-2 fusion protein through genetic engineering |
| 07/28/2010 | CN101787072A Specific binding agents of human angiopoietin-2 |
| 07/28/2010 | CN101016547B Method of preparing ocean double RNA virus MABV recombination albumen and application thereof |
| 07/27/2010 | US7763446 nucleic acids encoding a chimeric protein comprising a cleavage domain and a composite nucleic acid-binding region, that comprises at least two component polypeptide portions which are individually capable of binding specific nucleotide sequences |
| 07/27/2010 | US7763443 Expression vector comprising nucleotide sequences coding green fluorescent protein for use as reporter molecule in gene expression analysis |
| 07/27/2010 | US7763258 Used to assess protein binding interactions |
| 07/27/2010 | CA2223300C Expression of lipoproteins |
| 07/27/2010 | CA2195385C An artificial recombinant substrate (ragg 1) and native aggrecan to study the proteolytic activity of 'aggrecanase' in cell culture systems |
| 07/22/2010 | WO2010083253A2 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 07/22/2010 | WO2010083225A2 Targeted cryptosporidium biocides |
| 07/22/2010 | WO2010082804A2 Method for producing physiologically active protein or peptide using immunoglobulin fragment |
| 07/22/2010 | WO2010051502A3 Light targeting molecules and uses thereof |
| 07/22/2010 | WO2010037135A3 Compounds for reversing and inhibiting protein aggregation, and methods for making and using them |
| 07/22/2010 | US20100184951 Truncated BAFF Receptors |
| 07/22/2010 | US20100184619 Method for analyzing organelle-localized protein and material for analysis |
| 07/22/2010 | US20100184116 Fluorescent protein |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183560 Angiogenesis-modulating compositions and uses |
| 07/21/2010 | EP2207797A1 Modulation of sirpalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 07/21/2010 | EP1124961B9 Thrombopoietic compounds |
| 07/21/2010 | CN101781370A Recombination fusion protein of soluble vascular endothelial growth factor receptor and application thereof |
| 07/21/2010 | CN101781369A Recombinant human arginase fusion protein and application thereof |
| 07/20/2010 | US7759467 increasing fficiency of transduction of hematopoietic cells; infecting cells in presence of fibronectin; stem cells; gene therapy; efficient retroviral infection of mammalian cells |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7759078 Diagnosis and treatment of cancer |
| 07/20/2010 | US7758858 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 07/20/2010 | CA2421339C Novel polypeptides and nucleic acids encoding the same |
| 07/20/2010 | CA2389250C Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 07/20/2010 | CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it |
| 07/15/2010 | WO2010081095A2 Methods and compositions for inhibiting hepatitis c virus replication |
| 07/15/2010 | WO2010080248A2 Peptides that bind eukaryotic translation initiation factor 4e |
| 07/15/2010 | WO2010079594A1 Sterol side chain-cleaving enzyme protein and use thereof |
| 07/15/2010 | US20100178292 Cryptic glycan markers and applications thereof |
| 07/15/2010 | DE102007042107B4 Pharmazeutische Zusammensetzung mit eisenbindendem Agens A pharmaceutical composition comprising eisenbindendem agent |
| 07/14/2010 | EP2206776A1 Mite antigenic rice |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2205729A2 Genomic editing in zebrafish using zinc finger nucleases |
| 07/14/2010 | CN101775072A Glial cell line-Derived Neurotrophic Factor (GDNF) fusing penetrating peptides |
| 07/13/2010 | US7754855 comprising a full-length human erythropoietin protein joined without an intervening peptide linker to a human immunoglobulin domain; making fusion proteins comprising a cytokine or growth factor fused to an immunoglobulin domain; treating deficient hematocrit; purification |
| 07/13/2010 | US7754853 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 07/13/2010 | US7754678 fusion proteins; drug delivery |
| 07/13/2010 | CA2474734C Thermostable taq polymerase fragment |
| 07/13/2010 | CA2420350C Membrane penetrating peptides and uses thereof |
| 07/13/2010 | CA2345932C Peptide-based carrier devices for stellate cells |
| 07/13/2010 | CA2245242C Purified sr-p70 protein |
| 07/13/2010 | CA2183564C Methods for altering fertility |
| 07/08/2010 | WO2010075770A1 A recombinant fusion protein, the preparation method and use thereof |
| 07/08/2010 | WO2010042828A3 Methods and compositions relating to e3 ring-e2 fusion proteins |
| 07/08/2010 | US20100172968 Chimeric cannulae proteins and methods for making and using them |
| 07/08/2010 | CA2746228A1 Modified rsv f proteins and methods of their use |
| 07/07/2010 | EP2204385A1 Pseudomonas exotoxin A mutants and uses thereof |
| 07/07/2010 | EP2203476A2 Compositions and methods for inhibiting interleukin pathways |
| 07/07/2010 | EP2203474A1 Method for purifying fc-fusion proteins |
| 07/07/2010 | EP2203180A1 Single ifn-beta fused to a mutated igg fc fragment |